NEJM Interviews

500 episodes listed below

Listen to the show on

Measured medicine, policy, and evidence.

The gist

NEJM Interviews is a careful interview series from the New England Journal of Medicine, centered on clinical research, health care, and policy decisions. Recent episodes examine graduate nursing loan limits, vaccine guidance, private equity, trainee billing, influenza, and contested evidence around leucovorin.

PRESS PLAY

Find your next episode

All episodes

About NEJM Interviews

NEJM Interviews is the audio counterpart to careful medical reading: structured, direct, and built around questions that matter in clinics, hospitals, and policy rooms. The show favors explanation over velocity. A typical episode begins with a defined pressure point, such as a federal loan policy, a vaccine recommendation, or a shift in hospital ownership. From there, the guest is given room to explain origins, mechanisms, tradeoffs, and consequences. The recent run is broad but coherent. One conversation examines proposed caps on graduate nursing loans and asks what evidence-based policymaking should mean for workforce education. Another looks at family physicians trying to address social determinants of health and the cumulative harms of discrimination through practical tools and community-clinical linkages. A discussion of corporate health care asks how organizations affect physicians’ intrinsic motivation when much of high-quality care cannot be measured at scale. The show also pays attention to training. Competency-based medical education becomes a billing question when senior residents deliver real care under supervision that Medicare rules may not fully recognize. Public health episodes are equally grounded. Childhood vaccine-schedule changes are treated as a communication problem for parents and clinicians, not simply as a political fight. Influenza coverage links pediatric illness, vaccination rates, global surveillance, egg-based production, and newer vaccine technologies. The series is comfortable with uncertainty. In the leucovorin episode, the conversation separates a rare cerebral folate deficiency indication from broader autism-related use where evidence remains limited. Private equity coverage connects ownership practices to staffing cuts, service closures, access, and quality of care for disadvantaged communities. The tone is measured and institutional, but not cold. It works because the questions are concrete and the answers are allowed to develop. NEJM Interviews is best for listeners who want the machinery behind medical headlines: laws, incentives, evidence standards, clinical judgment, and the people affected when those forces collide.

Made for: For clinicians, health policy watchers, medical trainees, researchers, and serious general listeners who want calm context on current health care debates. It rewards attention to systems, evidence, and bedside consequences.

What sets it apart: The series pairs journal-level subject matter with concise, question-led interviews that keep returning to practical consequences. It is less about opinion and more about how policies, evidence, and institutions shape care.

In their own words

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

As heard by us

Based on 4 episodes we listened to · September 2026

Careful interviews connect changing medical evidence to the regulations, payment systems and public-health decisions that determine how care reaches people.

NEJM Interviews follows medical decisions past the evidence and into the systems that put them into practice. Conversations led by Harleen Marwa or Stephen Morrissey ask how clinical tools, regulations and public programs acquire authority, then press guests on what happens when…

Read our full review in PlayNext →

Why you'd press play

A lung-function equation enters the clinic; you follow its consequences into workers' compensation.

Press play if you want

  • someone to trace race-based clinical rules from sincere intent to unequal consequences
  • a state-level H5N1 briefing that tells you what backyard-flock owners should actually do
Read the full recommendation in PlayNext →
clinical research and evidence standardshealth care policymedical education and traininghealth equityvaccination guidancecorporatization of health carepatient access and quality of carepublic health communication

Talks about

Best episodes of NEJM Interviews

Short reviews from the PlayNext desk, based on the episodes we processed.

NEJM Interview: David Jones on the disparate historical approaches to anemia diagnosis and their lessons for physicians.

How anemia standards changed says as much about medicine as the lab numbers do.

The piece follows how anemia diagnosis moved away from race-based standards, and it explains why that shift took so long. Dr. Jones gives the history room to breathe, and the strongest moments come when he treats the older race-specific tools as sincere efforts, made by people…

NEJM Outbreaks Update — H5N1: A View from the States

A clear, state-level look at how H5N1 response turns public guidance into practice.

It treats H5N1 as a public-health problem that is still mostly animal-driven, with limited human infection, and it keeps that frame steady throughout.

NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity.

A clear policy conversation on how elections can shape coverage, Medicare costs, and whose health needs reach government.

NEJM Interviews frames the 2024 U.S. elections as a health policy hinge, following how the next president and Congress could shape insurance coverage, access, affordability, and health equity. Jose Figueroa, of the Harvard T.H.

Podcasts like NEJM Interviews

Episodes

  1. 1

    NEJM Interview: Erin Fuse Brown on telehealth arrangements that have prompted concerns about inappropriate prescribing and unnecessary spending.

    ·10m
  2. 2

    NEJM Interview: Daniel Aaron on a Supreme Court case about e-cigarettes that could have implications for the FDA’s authority and for public health.

    ·9m
  3. 3

    NEJM Interview: Benjamin Rome on the results of the initial round of drug-price negotiation under the Inflation Reduction Act.

    ·10m
  4. 4

    NEJM Interview: Karen Joynt Maddox on the Transforming Episode Accountability Model recently announced by CMS.

    ·11m
  5. 5

    NEJM Interview: Carmel Shachar on modernizing labor laws and strike regulations to support physicians, patients, and hospitals.

    ·9m
  6. 6

    NEJM Interview: Patricia Zettler on a proposed FDA rule on nicotine yields and potential challenges moving forward.

    ·8m
  7. 7

    NEJM Interview: Heather Hsu on an institutional conference series that provides opportunities for addressing the adverse effects of bias and medical racism.

    ·8m
  8. 8

    NEJM Interview: Alice Chen on responding to the U.S. administration’s threats to health and physicians’ values and maintaining hope in difficult times.

    ·11m
  9. 9

    NEJM Interview: Andrew Hantel on a source of discrimination against some patients in cancer research and care practices.

    ·13m
  10. 10

    NEJM Interview: Leemore Dafny on the implications of corporatization of the U.S. health insurance industry.

    ·11m
  11. 11

    NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer

    ·3m
  12. 12

    NEJM Interview: Joey Mattingly on providing widespread access to HCV treatment at the lowest possible price.

    ·12m
  13. 13

    NEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 Diabetes

    ·3m
  14. 14

    NEJM Interview: Amanda Kallen on the history of women’s health research and recent actions that are jeopardizing progress in women’s health.

    ·13m
  15. 15

    NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services.

    ·10m
  16. 16

    NEJM at AHA — CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy

    ·4m
  17. 17

    NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors

    ·3m
  18. 18

    NEJM Interview: Bruce Chabner on recent FDA statements regarding potential uses for leucovorin.

    ·7m
  19. 19

    NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer

    ·2m
  20. 20

    NEJM Interview: Abigail Cutler on providing training in abortion care to Ob/Gyn residents amid legal restrictions.

    ·10m
  21. 21

    NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease

    ·5m
  22. 22

    NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer

    ·3m
  23. 23

    NEJM Interview: Lauren Jatt on the efficacy of twice-yearly lenacapavir for preexposure prophylaxis and its implications for the development of an HIV vaccine.

    ·8m
  24. 24

    NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform.

    ·9m
  25. 25

    NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications.

    ·12m
  26. 26

    NEJM Interview: Carmel Shachar on the opportunities and risks presented by the Rural Health Transformation Program.

    ·8m
  27. 27

    NEJM Interview: Lauren Schiff on the need for improved training and increased comfort in treating autistic people.

    ·13m
  28. 28

    NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States.

    ·11m
  29. 29

    NEJM Interview: Rohan Khazanchi on the gradual but incomplete shift to race-free equations for interpreting pulmonary function tests.

    Dr.

    ·31m·3 clips
  30. 30

    NEJM Interview: Darshali Vyas on campaigns to remove race from clinical algorithms.

    ·10m
  31. 31

    NEJM Interview: Erin Fuse Brown on the manifestations and effects of corporatization in health care.

    ·11m
  32. 32

    NEJM Interview: Charles Weijer on the potential benefits and ethical challenges associated with pragmatic and cluster RCTs.

    ·12m
  33. 33

    NEJM Interview: Vincent Guilamo-Ramos on the need to rethink the response to HIV in Latino communities.

    ·7m
  34. 34

    NEJM Interview: Liam McCoy on concerns about the implementation of large language models in note writing and related clinical tasks.

    ·14m
  35. 35

    NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine.

    ·11m
  36. 36

    NEJM Interview: Danielle Jones on the development of tools to help family physicians address social determinants of health and advance health equity.

    ·7m
  37. 37

    NEJM at AHA — Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

    ·4m
  38. 38

    NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

    ·4m
  39. 39

    NEJM Interview: Michael Liu on a new model that will expand the use of prior authorization in traditional Medicare.

    ·10m
  40. 40

    NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity.

    Hidden gem

    The interview asks how the 2024 U.S.

    ·21m·1 clip
  41. 41

    NEJM Interview: John Ayanian on opportunities to study the health and economic effects of Medicaid work requirements and to mitigate their adverse consequences.

    ·11m
  42. 42

    NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction

    ·4m
  43. 43

    NEJM at AHA — Left Atrial Appendage Closure after Ablation for Atrial Fibrillation

    ·4m
  44. 44

    NEJM Interview: Amanda Janitz on a navigation program aimed at improving cancer outcomes for American Indian and Alaska Native patients.

    ·6m
  45. 45

    NEJM Interview: Katie Watson on the interaction of abortion laws with advance-directive and end-of-life laws.

    ·13m
  46. 46

    NEJM Interview: Ruqaiijah Yearby on recent trends in health care markets and their implications for health equity.

    ·7m
  47. 47

    NEJM Interview: Nancy Krieger on the effects of structural racism on health and health care and the conflation of research on health equity with DEI work.

    ·10m
  48. 48

    NEJM Interview: Amitabh Chandra on why corporatization occurs in health care, when it can succeed, and why it can go wrong.

    ·13m
  49. 49

    NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

    ·3m
  50. 50

    NEJM Interview: David Jones on the disparate historical approaches to anemia diagnosis and their lessons for physicians.

    Hidden gem

    Dr.

    ·40m·2 clips
  51. 51

    NEJM Interview: Craig Spencer on the need for action to address persistent inequities in global health.

    ·18m
  52. 52

    NEJM Interview: Arthur Robin Williams on alcohol consumption in the United States and the effects of alcohol taxes.

    ·9m
  53. 53

    NEJM Interview: John Patrick Co on a stipend program designed to address cost-of-living concerns for residency applicants.

    ·5m
  54. 54

    NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.

    ·10m
  55. 55

    NEJM Interview: Bindu Kanapuru on the FDA’s new expedited withdrawal procedure for accelerated approvals.

    ·9m
  56. 56

    NEJM Outbreaks Update — H5N1

    ·19m
  57. 57

    NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders.

    This interview discusses recent federal actions undermining harm-reduction programs for substance use disorders, with expert Joshua Barocas explaining the definition, evidence, and benefits of such interventions.

    ·13m
  58. 58

    NEJM Interview: Sonja Rasmussen on the 2025–2026 influenza season, including factors contributing to the intensity of influenza activity.

    ·6m
  59. 59

    NEJM Interview: Tara Eicher on changes in autism diagnosis in recent years and statements from the federal government regarding autism.

    ·14m
  60. 60

    NEJM Interview: Tara Sklar on U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency.

    ·12m
  61. 61

    The Marburg Virus Outbreak in Rwanda

    ·33m
  62. 62

    NEJM Interview: Sara Gerke on the potential for genetic data and other personal information to be included in business transactions in the United States.

    ·7m
  63. 63

    NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern.

    ·9m
  64. 64

    NEJM Interview: Robert Kocher on strategies for improving blood-pressure control in the United States.

    ·7m
  65. 65

    NEJM Interview: Zirui Song on the rise of concierge and direct primary care practices in the United States.

    ·13m
  66. 66

    NEJM Interview: Peter Marks on the disruption of traditional approaches to establishing Covid-19 vaccine policy in the United States.

    ·10m
  67. 67

    NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

    ·3m
  68. 68

    NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

    ·4m
  69. 69

    NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend.

    ·8m
  70. 70

    NEJM Interview: Abbas Hassan on the gap between the services that residents and fellows provide and the revenue that hospitals can capture.

    ·9m
  71. 71

    NEJM Interview: Benjamin Chrisinger on proposed changes to the Supplemental Nutrition Assistance Program and other options for promoting improved health.

    ·9m
  72. 72

    NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization.

    ·8m
  73. 73

    NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease.

    ·10m
  74. 74

    NEJM Interview: Christopher Duggan on the effects of ending U.S. foreign-assistance and global health programs.

    ·7m
  75. 75

    NEJM Outbreaks Updates — H5N1 in Indiana

    This episode discusses the H5N1 outbreak in Indiana with Dr.

    ·21m
  76. 76

    NEJM Interview: I. Glenn Cohen on the professional implications of the use of artificial-intelligence–based monitoring systems in medicine.

    ·7m
  77. 77

    NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia

    ·3m
  78. 78

    NEJM Interview: Lawrence Casalino on qualities of corporate organizations that could affect physicians’ intrinsic motivation and the quality of the care they provide.

    ·13m
  79. 79

    NEJM Interview: Andrew Gabrielson on cuts to the U.S. research agency charged with safeguarding workers’ health.

    ·6m
  80. 80

    NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy.

    ·15m
  81. 81

    NEJM Interview: Steven Lipstein on the drivers and the benefits of mergers and consolidation, from the perspective of a health care system leader.

    ·12m
  82. 82

    NEJM at ESMO — Ponsegromab in Cancer Cachexia

    ·3m
  83. 83

    NEJM Interview: Lawrence Casalino on qualities of corporate organizations that could affect physicians’ intrinsic motivation and the quality of the care they provide.

    ·13m
  84. 84

    NEJM Interview: Nicholas Bagley on the Supreme Court’s decision in a case with implications for coverage of preventive services.

    ·14m
  85. 85

    NEJM Interview: John Kelly on shifts in approaches for addressing substance use disorder.

    This interview with Dr.

    ·11m
  86. 86

    NEJM Interview: Dariush Mozaffarian on the health harms of ultraprocessed foods and related policy actions.

    ·17m
  87. 87

    NEJM Interview: Mark Wicclair on approaches to protecting both physicians’ conscience and patients’ health.

    ·8m
  88. 88

    NEJM Interview: Tom Frieden on the role of the CDC and current threats to the U.S. public health infrastructure.

    ·11m
  89. 89

    NEJM Interview: Nancy Tomes on the century-long transition to a corporate business model in U.S. health care.

    ·17m
  90. 90

    NEJM Interview: Jason Schwartz on changes to the Advisory Committee on Immunization Practices and approaches to sustaining U.S. vaccination efforts.

    ·9m
  91. 91

    NEJM Interview: Douglas Opel on the importance of clinician–parent communication amid changes to the childhood vaccine schedule.

    ·9m
  92. 92

    NEJM Interview: Danielle Jones on the development of tools to help family physicians address social determinants of health and advance health equity.

    Stephen Morrissey interviews Danielle Jones about the American Academy of Family Physicians' Every One Project toolkit.

    ·7m
  93. 93

    NEJM Interview: Amar Kelkar on NIH indirect-cost coverage and U.S. medical research.

    ·8m
  94. 94

    NEJM Interview: David Velasquez on care for older, low-income adults who can’t enroll in Medicare or Medicaid because they’re undocumented immigrants.

    ·12m
  95. 95

    NEJM Interview: Peter Ubel on strategies for protecting patients from high out-of-pocket costs for drugs with questionable benefits.

    ·7m
  96. 96

    NEJM Outbreaks Update — H5N1: A View from the States

    Hidden gem

    Stephen Morrissey opens by resetting what H5N1 currently looks like.

    ·35m·2 clips
  97. 97

    NEJM Interview: Patricia Mae Santos on the effects of U.S. anti-immigrant policies on immigrant health care workers and their patients.

    ·11m
  98. 98

    NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma

    ·3m
  99. 99

    NEJM Interview: Joseph Ross on the newly implemented Cell and Gene Therapy Access Model.

    ·8m
  100. 100

    NEJM Interview: Rochelle Walensky on the increased workload and emotional and financial burden associated with applying to medical school.

    ·13m
  101. 101

    NEJM Interview: Alex Keuroghlian on responding to policy threats to protections for transgender and nonbinary people.

    ·10m
  102. 102

    NEJM Interview: Yashaswini Singh on the expansion of private equity investments in health care and actions to safeguard patient interests in various countries.

    ·12m
  103. 103

    NEJM Interview: Benjamin Scher on opioid litigation and governance systems for spending related funds.

    Sep 30, 2026·9m
  104. 104

    NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends.

    Sep 23, 2026·13m
  105. 105

    NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory.

    Sep 16, 2026·9m
  106. 106

    NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services.

    Sep 9, 2026·12m
  107. 107

    NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.

    Sep 2, 2026·12m
  108. 108

    NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.

    Aug 19, 2026·13m
  109. 109

    NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.

    Aug 12, 2026·9m
  110. 110

    NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.

    Aug 5, 2026·11m
  111. 111

    NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.

    Jul 29, 2026·14m
  112. 112

    NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines.

    Jul 22, 2026·9m
  113. 113

    NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care.

    Jul 15, 2026·8m
  114. 114

    NEJM Interview: Mark Unruh on projected increases in the need for long-term services and supports in the United States amid declines in nursing-home capacity.

    Jul 8, 2026·6m
  115. 115

    NEJM Interview: Justin Barr on physician leadership in American society and politics over the past 250 years.

    Jul 1, 2026·11m
  116. 116

    NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss.

    Jun 24, 2026·13m
  117. 117

    NEJM Interview: Marcus Hughes on inconsistent oversight of psychedelic agents at the state and federal levels in the United States.

    Jun 17, 2026·9m
  118. 118

    NEJM Interview: Edward Ryan on factors driving continued disease and death from cholera and opportunities for progress.

    Jun 10, 2026·12m
  119. 119

    NEJM Interview: Loren Adler on regulatory strategies for addressing factors that make consolidation in health care especially profitable.

    Jun 3, 2026·10m
  120. 120

    NEJM Interview: Deirdre Tobias on the 2025–2030 Dietary Guidelines for Americans, including areas of confusion and contradiction.

    May 27, 2026·14m
  121. 121

    NEJM Outbreaks Updates — Andes Hantavirus

    Hidden gem

    NEJM Interviews examines an Andes hantavirus outbreak aboard the MB Hondias, where 10 cases and three deaths were reported by May 13.

    May 26, 2026·28m·1 clip
  122. 122

    NEJM Interview: Raja-Elie Abdulnour on the need for clinicians and AI systems to refrain from expressing undue confidence in their knowledge.

    May 13, 2026·13m
  123. 123

    NEJM Interview: Jatin Vyas on the effect of corporatization of academic medical centers on medical education and trainee development.

    May 6, 2026·9m
  124. 124

    Introducing: Intention to Treat — Season 2

    Apr 29, 2026·3m
  125. 125

    NEJM Interview: Amanda Banks on concerns about a potential association between GLP-1 receptor agonists and restrictive eating disorders.

    Apr 29, 2026·10m
  126. 126

    NEJM Interview: Sara Gerke on a Utah pilot program involving an AI system that autonomously renews certain prescriptions.

    Apr 22, 2026·9m
  127. 127

    NEJM Interview: Amy Stimpfel on a new policy that would cap loans for graduate nursing and other students.

    This interview discusses new federal loan caps for graduate students, focusing on how nursing students are categorized differently from medical and dental students under the proposed policy.

    Apr 15, 2026·7m
  128. 128

    NEJM Interview: Danielle Jones on the development of tools to help family physicians address social determinants of health and advance health equity.

    This interview discusses the development of the AAFP's EVERYONE Project Toolkit to help family physicians address social determinants of health and advance health equity through community clinical linkages.

    Apr 8, 2026·7m
  129. 129

    NEJM Interview: Lawrence Casalino on qualities of corporate organizations that could affect physicians’ intrinsic motivation and the quality of the care they provide.

    This interview explores how corporate structures in healthcare affect physician motivation and care quality, focusing on unmeasurable aspects like timely diagnosis.

    Apr 1, 2026·13m
  130. 130

    NEJM Interview: Douglas Opel on the importance of clinician–parent communication amid changes to the childhood vaccine schedule.

    This interview discusses recent changes to the childhood vaccine schedule by the U.S.

    Mar 25, 2026·9m
  131. 131

    NEJM Interview: Abbas Hassan on the gap between the services that residents and fellows provide and the revenue that hospitals can capture.

    This episode discusses the gap between competency-based training for medical residents and fellows and outdated Medicare billing rules that affect hospital revenue.

    Mar 11, 2026·9m
  132. 132

    NEJM Interview: Ruqaiijah Yearby on recent trends in health care markets and their implications for health equity.

    Mar 4, 2026·7m
  133. 133

    NEJM Interview: Bruce Chabner on recent FDA statements regarding potential uses for leucovorin.

    Feb 25, 2026·7m
  134. 134

    NEJM Interview: Sonja Rasmussen on the 2025–2026 influenza season, including factors contributing to the intensity of influenza activity.

    Feb 18, 2026·6m
  135. 135

    NEJM Interview: Carmel Shachar on the opportunities and risks presented by the Rural Health Transformation Program.

    Feb 11, 2026·8m
  136. 136

    NEJM Interview: Leemore Dafny on the implications of corporatization of the U.S. health insurance industry.

    Feb 4, 2026·11m
  137. 137

    NEJM Interview: Robert Kocher on strategies for improving blood-pressure control in the United States.

    Jan 28, 2026·7m
  138. 138

    NEJM Interview: Tara Eicher on changes in autism diagnosis in recent years and statements from the federal government regarding autism.

    Jan 21, 2026·14m
  139. 139

    NEJM Interview: Tara Sklar on U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency.

    Jan 14, 2026·12m
  140. 140

    NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States.

    Jan 7, 2026·11m
  141. 141

    NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services.

    Dec 31, 2025·10m
  142. 142

    NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend.

    Dec 17, 2025·8m
  143. 143

    NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.

    Dec 10, 2025·10m
  144. 144

    NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy.

    Dec 3, 2025·15m
  145. 145

    NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications.

    Nov 26, 2025·12m
  146. 146

    NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine.

    Nov 19, 2025·11m
  147. 147

    NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders.

    Nov 12, 2025·13m
  148. 148

    NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization.

    Nov 5, 2025·8m
  149. 149

    NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease.

    Oct 22, 2025·10m
  150. 150

    NEJM Interview: Michael Liu on a new model that will expand the use of prior authorization in traditional Medicare.

    Oct 15, 2025·10m
  151. 151

    NEJM Interview: Andrew Gabrielson on cuts to the U.S. research agency charged with safeguarding workers’ health.

    Oct 8, 2025·6m
  152. 152

    NEJM Interview: Steven Lipstein on the drivers and the benefits of mergers and consolidation, from the perspective of a health care system leader.

    Oct 1, 2025·12m
  153. 153

    NEJM Interview: Nancy Krieger on the effects of structural racism on health and health care and the conflation of research on health equity with DEI work.

    Sep 24, 2025·10m
  154. 154

    NEJM Interview: John Ayanian on opportunities to study the health and economic effects of Medicaid work requirements and to mitigate their adverse consequences.

    Sep 17, 2025·11m
  155. 155

    NEJM Interview: Darshali Vyas on campaigns to remove race from clinical algorithms.

    Sep 10, 2025·10m
  156. 156

    NEJM Interview: Amanda Janitz on a navigation program aimed at improving cancer outcomes for American Indian and Alaska Native patients.

    Sep 10, 2025·6m
  157. 157

    NEJM Interview: Amitabh Chandra on why corporatization occurs in health care, when it can succeed, and why it can go wrong.

    Sep 3, 2025·13m
  158. 158

    NEJM Interview: Nicholas Bagley on the Supreme Court’s decision in a case with implications for coverage of preventive services.

    Aug 20, 2025·14m
  159. 159

    NEJM Interview: Tom Frieden on the role of the CDC and current threats to the U.S. public health infrastructure.

    Aug 13, 2025·11m
  160. 160

    NEJM Interview: Nancy Tomes on the century-long transition to a corporate business model in U.S. health care.

    Aug 6, 2025·17m
  161. 161

    NEJM Interview: Jason Schwartz on changes to the Advisory Committee on Immunization Practices and approaches to sustaining U.S. vaccination efforts.

    Jul 30, 2025·9m
  162. 162

    NEJM Interview: Rohan Khazanchi on the gradual but incomplete shift to race-free equations for interpreting pulmonary function tests.

    This episode discusses the shift to race-free equations for interpreting pulmonary function tests, exploring historical, clinical, and regulatory contexts, and strategies to address inequities in occupational health evaluations.

    Jul 30, 2025·31m
  163. 163

    NEJM Interview: Katie Watson on the interaction of abortion laws with advance-directive and end-of-life laws.

    Jul 23, 2025·13m
  164. 164

    NEJM Interview: Peter Marks on the disruption of traditional approaches to establishing Covid-19 vaccine policy in the United States.

    Jul 16, 2025·10m
  165. 165

    NEJM Interview: Patricia Mae Santos on the effects of U.S. anti-immigrant policies on immigrant health care workers and their patients.

    Jul 9, 2025·11m
  166. 166

    NEJM Interview: Erin Fuse Brown on the manifestations and effects of corporatization in health care.

    Jul 2, 2025·11m
  167. 167

    NEJM Interview: Dariush Mozaffarian on the health harms of ultraprocessed foods and related policy actions.

    Jun 25, 2025·17m
  168. 168

    NEJM Interview: I. Glenn Cohen on the professional implications of the use of artificial-intelligence–based monitoring systems in medicine.

    Jun 18, 2025·7m
  169. 169

    NEJM Interview: Amanda Kallen on the history of women’s health research and recent actions that are jeopardizing progress in women’s health.

    Jun 11, 2025·13m
  170. 170

    NEJM Interview: Amar Kelkar on NIH indirect-cost coverage and U.S. medical research.

    Jun 4, 2025·8m
  171. 171

    NEJM Interview: David Jones on the disparate historical approaches to anemia diagnosis and their lessons for physicians.

    This episode features an interview with Dr.

    Jun 4, 2025·40m
  172. 172

    NEJM Interview: Zirui Song on the rise of concierge and direct primary care practices in the United States.

    May 28, 2025·13m
  173. 173

    NEJM Interview: Alice Chen on responding to the U.S. administration’s threats to health and physicians’ values and maintaining hope in difficult times.

    May 14, 2025·11m
  174. 174

    NEJM Interview: Christopher Duggan on the effects of ending U.S. foreign-assistance and global health programs.

    May 7, 2025·7m
  175. 175

    NEJM Interview: Arthur Robin Williams on alcohol consumption in the United States and the effects of alcohol taxes.

    Apr 30, 2025·9m
  176. 176

    NEJM Interview: Lauren Jatt on the efficacy of twice-yearly lenacapavir for preexposure prophylaxis and its implications for the development of an HIV vaccine.

    Apr 23, 2025·8m
  177. 177

    NEJM Interview: Erin Fuse Brown on the potential implications of recent Supreme Court decisions for health law and policy.

    Sep 4, 2024·12m
  178. 178

    NEJM at ESC — Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk

    Sep 1, 2024·3m
  179. 179

    NEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection Fraction

    Aug 31, 2024·3m
  180. 180

    NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease

    Aug 31, 2024·4m
  181. 181

    NEJM at ESC — Asundexian versus Apixaban in Patients with Atrial Fibrillation

    Aug 31, 2024·4m
  182. 182

    NEJM at ESC — Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction

    Aug 31, 2024·3m
  183. 183

    NEJM at ESC — Transcatheter Repair versus Surgery for Secondary Mitral Regurgitation

    Aug 30, 2024·4m
  184. 184

    NEJM at ESC — Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation

    Aug 30, 2024·3m
  185. 185

    NEJM at ESC — Inflammation, Cholesterol, Lipoprotein(a) and 30-Year Cardiovascular Outcomes in Women

    Aug 30, 2024·4m
  186. 186

    NEJM at ESC — Continuation versus Interruption of Oral Anticoagulation during TAV

    Aug 30, 2024·5m
  187. 187

    NEJM at ESC — PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation

    Aug 30, 2024·4m
  188. 188

    NEJM at ESC — Beta Blocker Interruption or Continuation with Prior Myocardial Infarction

    Aug 29, 2024·4m
  189. 189

    NEJM at ESC — Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

    Aug 29, 2024·3m
  190. 190

    NEJM Interview: Revati Masilamani on a multitiered mentoring program aimed at supporting pathways to biomedical careers for students from diverse backgrounds.

    Aug 21, 2024·13m
  191. 191

    NEJM Interview: Barron Lerner on challenges to physician expertise and restoring trust in the medical profession.

    Aug 14, 2024·8m
  192. 192

    NEJM Interview: Gregg Gonsalves on the Covid pandemic’s lessons for addressing H5N1 influenza and other infectious threats.

    Aug 7, 2024·8m
  193. 193

    NEJM Interview: Elizabeth Tobin-Tyler on the contribution of violence against women to unwanted pregnancies and to injury and death during the peripartum period.

    Jul 24, 2024·11m
  194. 194

    NEJM Interview: Ida Sim on the translation of ethical principles into oversight of new forms of artificial intelligence.

    Jul 17, 2024·14m
  195. 195

    NEJM Interview: Erin Fuse Brown on a vertical-consolidation trend that has given insurance companies increased control over the care-delivery system.

    Jul 10, 2024·11m
  196. 196

    NEJM Interview: Evan Mullen on academic institutions’ participation in public debate, including in response to the opinions of their faculty members.

    Jul 3, 2024·10m
  197. 197

    NEJM Interview: Nathaniel Chin on increases in the time and resources needed to diagnose and manage neurodegenerative diseases.

    Jun 26, 2024·10m
  198. 198

    NEJM Interview: Christine Grady on the ethical challenges associated with recent developments in research on brain diseases.

    Jun 19, 2024·17m
  199. 199

    NEJM Interview: Jessica Lewis on a group prenatal care program aimed at improving maternal and infant health in diverse patient populations.

    Jun 12, 2024·9m
  200. 200

    NEJM Interview: Katharine Silbaugh on an approach to tobacco regulation that involves banning the sale of nicotine products to anyone born after a certain date.

    May 29, 2024·7m
  201. 201

    Preparing for a Possible Avian Influenza Outbreak

    May 21, 2024·32m
  202. 202

    Preparing for a Possible Avian Influenza Outbreak

    May 19, 2024·38m
  203. 203

    NEJM Interview: Alicia Fernandez on the need for a focus on equity in patient experience and clinical outcomes in the health care sector.

    May 15, 2024·10m
  204. 204

    NEJM Interview: Joshua Sharfstein on a shift by the Supreme Court that is limiting the ability of states, Congress, and federal agencies to protect public health.

    May 8, 2024·13m
  205. 205

    NEJM Interview: Kevin Schulman on unionization as a response to consolidation and corporatization in health care.

    Apr 24, 2024·10m
  206. 206

    NEJM Interview: Stephanie Fullerton on the rise of clinical genetic testing and related ethical considerations.

    Apr 17, 2024·10m
  207. 207

    NEJM Interview: R. Alta Charo on the potential implications of the Alabama Supreme Court’s decision in LePage v. Center for Reproductive Medicine.

    Apr 10, 2024·14m
  208. 208

    NEJM Interview: Daniel Sulmasy on the role of spirituality in patient care.

    Mar 20, 2024·9m
  209. 209

    NEJM Interview: Dhruv Khullar on the trend of hospital acquisition of physician practices in the United States.

    Mar 13, 2024·9m
  210. 210

    NEJM Interview: José Rodríguez on an intervention aimed at recruiting a diverse class into a family medicine residency program.

    Feb 28, 2024·18m
  211. 211

    NEJM Interview: Ilya Golovaty on platforms offering direct-to-consumer prescribing of medications for weight management.

    Feb 21, 2024·16m
  212. 212

    NEJM Interview: Dave Chokshi on ethical issues faced by safety-net health systems in the United States.

    Feb 14, 2024·12m
  213. 213

    NEJM Interview: David Higgins on public confidence in the value of childhood vaccines and the importance of combating misinformation about vaccination.

    Feb 7, 2024·6m
  214. 214

    Not Otherwise Specified

    Jan 24, 2024·4m
  215. 215

    NEJM Interview: Andrew Lea on how experience with a 1970s computerized diagnostic program can inform efforts to implement machine-learning prediction models in medicine.

    Jan 24, 2024·9m
  216. 216

    NEJM Interview: Thomas Gallagher on historical and current ethical approaches to responding to harmful medical errors.

    Jan 17, 2024·17m
  217. 217

    NEJM Interview: Joseph Friedman on increases in drug-related mortality among adolescents and approaches to overdose prevention.

    Jan 10, 2024·10m
  218. 218

    NEJM Interview: Crystal Cené on the potential benefits, particularly for Black birthing people, of partnerships between perinatal care providers and community-based doulas.

    Dec 27, 2023·15m
  219. 219

    NEJM Interview: Bernard Lo on the evolution of the ethical and legal framework for making medical decisions for patients who lack decision-making capacity.

    Dec 20, 2023·10m
  220. 220

    NEJM Interview: Laura Stark on the history of rules governing human-subjects research and potential lessons for the regulation of artificial intelligence.

    Dec 13, 2023·10m
  221. 221

    Is Xenotransplantation Ready for Prime Time? — ITT Episode 22

    Dec 6, 2023·24m
  222. 222

    NEJM Interview: Robert Yeh on delays between FDA authorization and Medicare coverage of new medical devices and proposed reforms to current systems.

    Nov 29, 2023·10m
  223. 223

    NEJM Interview: Hao Yu on a new Tennessee law that expands practice opportunities for some international medical graduates.

    Nov 22, 2023·9m
  224. 224

    NEJM Interview: Nelson Wandera on an outbreak of Rift Valley fever virus in Uganda and an approach aimed at advancing surveillance, treatment, and research.

    Nov 15, 2023·14m
  225. 225

    NEJM Interview: Mason Marks on draft guidance on psychedelics research.

    Nov 8, 2023·17m
  226. 226

    NEJM Interview: David Grabowski on a proposed federal rule mandating a specific minimum-staffing standard for U.S. nursing homes.

    Nov 1, 2023·9m
  227. 227

    NEJM Interview: Kekoa Taparra on the Lāhainā fires and persistent threats to community recovery.

    Oct 25, 2023·10m
  228. 228

    NEJM Interview: Peter Hotez on concerns that yellow fever could return to the southern United States.

    Oct 18, 2023·9m
  229. 229

    NEJM Interview: Joelle Abi-Rached on the social, political, economic, and ethical factors that go into a decision to declare that a public health crisis is over.

    Oct 11, 2023·14m
  230. 230

    NEJM Interview: Rosemary Sokas on the risk of heat-related illness among U.S. workers as temperatures increase.

    Oct 4, 2023·14m
  231. 231

    NEJM Interview: Atheendar Venkataramani on affirmative action and how hope and opportunity can affect health and well-being.

    Sep 27, 2023·9m
  232. 232

    NEJM Interview: Steven Woloshin on an updated U.S. Preventive Services Task Force recommendation regarding the starting age for mammography screening.

    Sep 20, 2023·7m
  233. 233

    NEJM Interview: Erin Fuse Brown on the role of corporate-practice-of-medicine laws in a changing health care environment.

    Sep 13, 2023·7m
  234. 234

    NEJM Interview: Salim Abdool Karim on a National Institutes of Health policy that will add new requirements for foreign subrecipients of funding.

    Sep 6, 2023·8m
  235. 235

    NEJM Interview: Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2.

    Aug 30, 2023·9m
  236. 236

    NEJM Interview: Valerie Montgomery Rice on opportunities for achieving a diverse student body and workforce after the Supreme Court’s decision on affirmative action.

    Aug 23, 2023·12m
  237. 237

    NEJM Interview: Catherine Godfrey on addressing mental health programming gaps for people living with HIV in Africa.

    Aug 16, 2023·5m
  238. 238

    NEJM Interview: Douglas Krakower on the potential benefits associated with making preexposure prophylaxis for HIV available without a prescription.

    Aug 9, 2023·19m
  239. 239

    NEJM Interview: Adam Rodman on the potential effects of generative artificial intelligence on medical education and clinical practice.

    Aug 2, 2023·10m
  240. 240

    NEJM Interview: David Blumenthal on opportunities to establish a national public health reporting system.

    Jul 26, 2023·9m
  241. 241

    NEJM Interview: Ge Bai on whether nonprofit hospitals provide enough community benefit to justify favored tax status.

    Jul 19, 2023·9m
  242. 242

    NEJM Interview: David Hunter on factors that have led to breakdowns in care in the United Kingdom’s National Health Service.

    Jul 12, 2023·14m
  243. 243

    NEJM Interview: Jean Nachega on PEPFAR’s achievements and remaining challenges in HIV prevention and treatment in sub-Saharan Africa.

    Jul 5, 2023·7m
  244. 244

    NEJM Interview: Sam Halabi on facilitating sharing and aggregation of pathogen genomic sequence data for public health objectives.

    Jun 28, 2023·10m
  245. 245

    NEJM Interview: Lawrence Gostin on political and scientific controversy about the emergence of SARS-CoV-2.

    Jun 21, 2023·11m
  246. 246

    NEJM Interview: Richard Mizelle on how long-standing issues related to structural racism culminated in a state of emergency in Mississippi in 2022.

    Jun 14, 2023·10m
  247. 247

    Dr. Fauci on Infectious Disease Challenges

    Jun 14, 2023·47m
  248. 248

    NEJM Interview: Clifford Rosen on gaps in the understanding of long Covid and in access to high-quality care for patients.

    Jun 7, 2023·10m
  249. 249

    NEJM Interview: William Riley on approaches to addressing current and projected platelet shortages in the United States.

    May 31, 2023·10m
  250. 250

    NEJM Interview: Kimani Paul-Emile on U.S. laws aimed at protecting against discrimination in health care contexts and why such discrimination endures.

    May 24, 2023·15m
  251. 251

    The Lasting Effects of Covid-19

    May 24, 2023·30m
  252. 252

    NEJM Interview: Ari Ne’eman on opportunities to support access to home- and community-based services for people with disabilities.

    May 17, 2023·14m
  253. 253

    NEJM Interview: Claire Ankuda on ensuring access to high-quality and equitable care in Medicare Advantage.

    May 10, 2023·10m
  254. 254

    Ending the Covid-19 Emergency

    May 10, 2023·19m
  255. 255

    NEJM Interview: Carolyn Gould on overcoming challenges related to developing vaccines for preventing West Nile virus disease.

    May 3, 2023·11m
  256. 256

    NEJM Interview: Prof. Arti Rai on U.S. legal regimes governing access to biomedical innovation.

    Apr 26, 2023·16m
  257. 257

    Preparing for the Next Pandemic

    Apr 26, 2023·26m
  258. 258

    NEJM Interview: Profs. Michelle Mello and Guy Palmer on wastewater surveillance during the Covid-19 pandemic and beyond.

    Apr 19, 2023·14m
  259. 259

    NEJM Interview: Prof. Elizabeth Tobin-Tyler on recent court decisions related to gun possession by people subject to certain types of restraining orders.

    Apr 12, 2023·12m
  260. 260

    When to Get a Second Covid-19 Booster Shot

    Apr 12, 2023·20m
  261. 261

    NEJM Interview: Dr. Joseph Ross on shifts in the FDA’s use of accelerated approval and associated challenges for clinicians and patients.

    Apr 5, 2023·12m
  262. 262

    NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic.

    Mar 29, 2023·6m
  263. 263

    Ending the Covid-19 Public Health Emergency

    Mar 29, 2023·19m
  264. 264

    NEJM Interview: Prof. Jaime King on the functions of antitrust law and the effects of health care consolidation on prices, quality of care, and access to care.

    Mar 22, 2023·14m
  265. 265

    NEJM Interview: Dr. Ashley Leech on the potential implications of Medicare Part D covering medications for obesity treatment.

    Mar 15, 2023·11m
  266. 266

    The Future of Covid-19 Research

    Mar 15, 2023·23m
  267. 267

    The Fauci Phenomenon

    Mar 8, 2023·28m
  268. 268

    NEJM Interview: Dr. Winfred W. Williams on strategies for recruiting and supporting medical students, trainees, and faculty from diverse backgrounds.

    Mar 8, 2023·7m
  269. 269

    NEJM Interview: Jeremiah Johnson on a proposed program to increase uptake of HIV preexposure prophylaxis and address disparities in access.

    Mar 1, 2023·13m
  270. 270

    The Path Forward for Covid-19 Therapeutics

    Mar 1, 2023·19m
  271. 271

    The Promise and Perils of Psychedelics

    Feb 22, 2023·30m
  272. 272

    NEJM Interview: Prof. Zack Buck on U.S. laws governing health care fraud and abuse and financial conflicts of interest.

    Feb 22, 2023·13m
  273. 273

    NEJM Interview: Dr. Konstantin Chumakov on current polio-immunization strategies and future directions for eradication efforts.

    Feb 15, 2023·15m
  274. 274

    What to Expect from Covid-19 Vaccines

    Feb 15, 2023·40m
  275. 275

    NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.

    Feb 8, 2023·12m
  276. 276

    NEJM Interview: Dr. Wafaa El-Sadr on navigating the current moment in the Covid-19 pandemic and learning lessons from past successes and missteps.

    Feb 1, 2023·10m
  277. 277

    Updating and Standardizing Covid-19 Vaccines

    Feb 1, 2023·22m
  278. 278

    NEJM Interview: Prof. Kimberly Mutcherson on the Dobbs v. Jackson Women’s Health Organization decision and states’ power to determine when life begins.

    Jan 25, 2023·12m
  279. 279

    NEJM Interview: Dr. Julianne Holt-Lunstad on the association between social connection and health.

    Jan 18, 2023·11m
  280. 280

    Weighing the Protective Value of Covid-19 Infection

    Jan 18, 2023·21m
  281. 281

    NEJM Interview: Dr. David Ansell and Redia Holman on an approach for health care institutions to build community health and wealth.

    Jan 11, 2023·17m
  282. 282

    Covid-19 Vaccines and New Viral Variants

    Jan 11, 2023·20m
  283. 283

    NEJM Interview: Prof. Michelle Mello on Braidwood Management Inc. v. Becerra and its potential implications.

    Jan 4, 2023·11m
  284. 284

    The Expanding Arsenal of Oral Agents to Treat Covid-19

    Jan 4, 2023·17m
  285. 285

    NEJM Interview: Dr. Armand Sprecher on the importance of mutual understanding in outbreak control, focusing on a recent outbreak of Sudan virus disease.

    Dec 28, 2022·6m
  286. 286

    NEJM AI Grand Rounds

    Dec 21, 2022·2m
  287. 287

    NEJM Interview: Prof. Sabrina Corlette on the history of the U.S. health insurance system and persistent coverage and affordability challenges.

    Dec 21, 2022·10m
  288. 288

    Potential Covid Vaccine Strategies

    Dec 21, 2022·22m
  289. 289

    NEJM Interview: Dr. David Blumenthal on a new federal rule that requires health care providers and other entities to share patient information.

    Dec 14, 2022·17m
  290. 290

    Applying New Studies of Mpox and Ebola to Covid-19

    Dec 14, 2022·21m
  291. 291

    NEJM Interview: Robert Shireman on policy changes allowing accreditation of for-profit medical schools in the United States

    Dec 7, 2022·8m
  292. 292

    Covid-19 and Health Equity

    Dec 7, 2022·44m
  293. 293

    NEJM Interview: Dr. Anthony Fauci on the evolution of the field of infectious diseases during his tenure at the National Institute of Allergy and Infectious Diseases.

    Nov 30, 2022·15m
  294. 294

    Five Disease Outbreaks beyond Covid-19

    Nov 30, 2022·20m
  295. 295

    NEJM Interview: Prof. Sharona Hoffman on laws protecting patients’ health information.

    Nov 23, 2022·9m
  296. 296

    Making Choices about Covid-19

    Nov 23, 2022·23m
  297. 297

    NEJM Interview: Dr. Ateev Mehrotra on federal pandemic-era telemedicine policies and research that could help inform permanent regulations.

    Nov 16, 2022·10m
  298. 298

    The FDA and Covid-19 Vaccines

    Nov 16, 2022·37m
  299. 299

    NEJM Interview: Dr. Mark Pallansch on an outbreak of imported poliovirus in the United States.

    Nov 9, 2022·12m
  300. 300

    Masking and Covid-19

    Nov 9, 2022·19m
  301. 301

    NEJM Interview: Dr. Srijan Sen on the current emphasis on distinguishing burnout from depression and possible unintended consequences for physician well-being.

    Nov 2, 2022·7m
  302. 302

    Caring for Hospitalized Patients with Covid-19

    Nov 2, 2022·28m
  303. 303

    NEJM Interview: Dr. David Studdert on the U.S. malpractice system and its effects on medical decision making.

    Oct 26, 2022·10m
  304. 304

    Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection

    Oct 26, 2022·16m
  305. 305

    NEJM Interview: Dr. Stacie Dusetzina on the potential effects of new legislation on spending on prescription drugs.

    Oct 19, 2022·11m
  306. 306

    Covid-19: Where Are We Heading?

    Oct 19, 2022·27m
  307. 307

    NEJM Interview: Dr. Rahul Gupta on strategies for promoting use of medication for opioid use disorder.

    Oct 12, 2022·9m
  308. 308

    Developing New Covid-19 Vaccines

    Oct 12, 2022·22m
  309. 309

    NEJM Interview: Prof. Michael Ulrich on the Supreme Court’s decision in New York State Rifle & Pistol Association v. Bruen and its implications for public health.

    Oct 5, 2022·13m
  310. 310

    Infectious Disease in Africa

    Oct 5, 2022·43m
  311. 311

    NEJM Interview: Dr. James Garbarino on the effects of exposure to gun violence on child and adolescent development.

    Sep 28, 2022·10m
  312. 312

    Assessing Bivalent Vaccines against Covid-19

    Sep 28, 2022·16m
  313. 313

    NEJM Interview: Prof. Nathan Cortez on legal and regulatory systems designed to prevent avoidable medical errors in the United States.

    Sep 21, 2022·9m
  314. 314

    Can Vaccines Prevent Transmission of Covid-19?

    Sep 21, 2022·15m
  315. 315

    NEJM Interview: Dr. Sonja Rasmussen on protecting pregnant people and babies from climate-change–related harm.

    Sep 14, 2022·9m
  316. 316

    Developing Mucosal Immunity to Covid-19

    Sep 14, 2022·17m
  317. 317

    NEJM Interview: Prof. Sara Rosenbaum on the conflict between EMTALA and restrictive state abortion laws.

    Sep 7, 2022·16m
  318. 318

    Rolling Out New Covid-19 Vaccines

    Sep 7, 2022·21m
  319. 319

    NEJM Interview: Dr. Eric Perakslis on cybersecurity threats to patients and health care systems.

    Aug 31, 2022·9m
  320. 320

    Covid-19 and the WHO

    Aug 31, 2022·33m
  321. 321

    NEJM Interview: Dr. Arthur Derse on the duties that physicians owe their patients and challenges to the physician–patient relationship.

    Aug 24, 2022·10m
  322. 322

    Choosing an Antiviral to Treat Covid-19

    Aug 24, 2022·20m
  323. 323

    NEJM Interview: Dr. Vivek Murthy on approaches to supporting well-being among health workers.

    Aug 17, 2022·14m
  324. 324

    Responding to Monkeypox

    Aug 17, 2022·31m
  325. 325

    NEJM Interview: Prof. Timothy Jost on litigation challenging the consideration of race and ethnicity in the allocation of scarce Covid-19 treatments.

    Aug 10, 2022·8m
  326. 326

    Combating Covid-19 Today and Tomorrow

    Aug 10, 2022·20m
  327. 327

    Updated Covid-19 Vaccines and a Look at Monkeypox

    Aug 3, 2022·21m
  328. 328

    NEJM Interview: Prof. Erin Fuse Brown on the history of health law in the United States and potential future directions for the field.

    Jul 27, 2022·13m
  329. 329

    Reinventing the Research Infrastructure to Address Covid-19

    Jul 27, 2022·27m
  330. 330

    NEJM Interview: Dr. Vinay Rathi on the medical device user-fee program and strategies for supporting device safety and innovation.

    Jul 20, 2022·11m
  331. 331

    A Look at the U.S. Government’s Covid-19 Strategy

    Jul 20, 2022·36m
  332. 332

    NEJM Interview: Dr. Rishi Wadhera on the inequitable effects of value-based payment programs and a new model meant to respond to equity concerns.

    Jul 13, 2022·11m
  333. 333

    Covid-19 Vaccines and the FDA

    Jul 13, 2022·31m
  334. 334

    NEJM Interview: Dr. Richard Baron on the role of certifying boards in addressing the problem of false information on social media.

    Jul 6, 2022·7m
  335. 335

    Designing the Next Covid-19 Vaccine

    Jul 6, 2022·27m
  336. 336

    NEJM Interview: Dr. Ankur Pandya on rigorously assessing the costs and benefits of various policy options for combating Covid-19.

    Jun 29, 2022·12m
  337. 337

    How Effective is Covid-19 Vaccination in Children?

    Jun 29, 2022·18m
  338. 338

    Vaccinating Young Children against Covid-19

    Jun 22, 2022·17m
  339. 339

    NEJM Interview: Dr. Ismail Jatoi on factors that have contributed to higher breast-cancer mortality among Black women than White women in the United States.

    Jun 22, 2022·8m
  340. 340

    NEJM Interview: Dr. Lauren Thaxton on the adverse effects on patients, physicians, and trainees of the new Texas abortion law.

    Jun 21, 2022·11m
  341. 341

    NEJM Interview: Prof. Lisa Heinzerling on West Virginia v. EPA and how the Supreme Court evaluates environmental and public health actions by federal agencies.

    Jun 15, 2022·9m
  342. 342

    Viral Evolution and the Future of Monoclonal Antibodies

    Jun 15, 2022·26m
  343. 343

    NEJM Interview: Dr. Leemore Dafny on a new approach for bringing down insulin prices in the United States.

    Jun 8, 2022·8m
  344. 344

    Protecting the Immunocompromised from Covid-19

    Jun 8, 2022·19m
  345. 345

    Dissecting the Host Response to SARS-CoV-2

    Jun 1, 2022·23m
  346. 346

    NEJM Interview: Dr. Elizabeth Samuels on overdose-prevention centers and federal policy.

    May 25, 2022·13m
  347. 347

    Waning Immunity against Covid-19

    May 25, 2022·14m
  348. 348

    NEJM Interview: Dr. Richard Pierson on the implications of recent efforts to transplant pig organs into humans.

    May 18, 2022·9m
  349. 349

    Audio of Perspective Roundtable on Long-Term Care in the United States

    May 13, 2022·50m
  350. 350

    NEJM Interview: Dr. Jonathan Oberlander on health care successes and struggles under the Biden administration.

    May 11, 2022·9m
  351. 351

    Forecasting the Future of Covid

    May 11, 2022·30m
  352. 352

    NEJM Interview: Dr. Lisa Harris on preparing for the effects on patients and trainees of the likely overturning of Roe v. Wade.

    May 10, 2022·17m
  353. 353

    NEJM Interview: Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.

    May 4, 2022·11m
  354. 354

    Do We Need New Covid-19 Vaccines?

    May 4, 2022·19m
  355. 355

    NEJM Interview: Dr. Abigail Friedman on policy approaches to combating adolescent vaping and helping adult smokers quit.

    Apr 27, 2022·10m
  356. 356

    Communicating Covid-19 Science

    Apr 27, 2022·34m
  357. 357

    NEJM Interview: Dr. Lois Lee on reductions in deaths from motor vehicle crashes among children and young adults and increases in firearm-related deaths.

    Apr 20, 2022·7m
  358. 358

    The Effects of Covid-19 on Children

    Apr 20, 2022·22m
  359. 359

    NEJM Interview: Dr. Hilary Seligman on reforming the Supplemental Nutrition Assistance Program to reduce food insecurity in the United States.

    Apr 13, 2022·11m
  360. 360

    Do the Tobacco Wars Offer Any Lessons for the Vaccine Wars?

    Apr 13, 2022·26m
  361. 361

    Do We Need a Fourth Dose of Covid Vaccine?

    Apr 6, 2022·22m
  362. 362

    NEJM Interview: Dr. Vikas Saini on the Choosing Wisely campaign and approaches for addressing low-value care.

    Apr 6, 2022·14m
  363. 363

    NEJM Interview: Prof. Christopher Robertson on the outcomes and implications of cases in which patients sued hospitals for access to ivermectin.

    Mar 30, 2022·6m
  364. 364

    Effectiveness of Covid-19 Vaccination in Children

    Mar 30, 2022·16m
  365. 365

    Covid-19 — Why We Publish What We Do

    Mar 23, 2022·21m
  366. 366

    NEJM Interview: Dr. Jorge Rodriguez on new U.S. legislation and the role of health care organizations in addressing digital divides.

    Mar 23, 2022·11m
  367. 367

    NEJM Interview: Dr. Melissa Wachterman on cultural factors and financial incentives driving where people in the United States choose to die.

    Mar 16, 2022·10m
  368. 368

    Can We Make More Effective Covid-19 Vaccines?

    Mar 16, 2022·23m
  369. 369

    NEJM Interview: Prof. Rachel Sachs on the balance between safeguarding access to high-quality care and constraining drug spending.

    Mar 9, 2022·7m
  370. 370

    Making Covid-19 Vaccines Available around the World

    Mar 9, 2022·35m
  371. 371

    Using Our Covid-19 Experience to Develop Vaccines More Quickly

    Mar 2, 2022·26m
  372. 372

    NEJM Interview: Prof. Michelle Mello on individual rights and state and federal powers to regulate health matters in the United States.

    Mar 2, 2022·10m
  373. 373

    NEJM Interview: Prof. Patricia Zettler on conflicts between state and federal law and access to mifepristone.

    Feb 23, 2022·8m
  374. 374

    Understanding the Omicron Variant of SARS-CoV-2

    Feb 23, 2022·25m
  375. 375

    NEJM Interview: Dr. Lee Fleisher on building a resilient health care delivery system that can maintain high safety levels in times of crisis.

    Feb 16, 2022·9m
  376. 376

    A New Antiviral against Covid-19

    Feb 16, 2022·25m
  377. 377

    Covid-19 as an Endemic Disease

    Feb 9, 2022·25m
  378. 378

    NEJM Interview: Dr. Joseph Graves, Jr. on socially defined races, human biologic variation, and disease.

    Feb 9, 2022·6m
  379. 379

    NEJM Interview: Dr. Tiffany Green on how economics can help guide public health policy.

    Feb 2, 2022·8m
  380. 380

    Studying Long Covid

    Feb 2, 2022·31m
  381. 381

    Addressing the Omicron Variant of SARS-CoV-2

    Jan 26, 2022·32m
  382. 382

    NEJM Interview: Dr. David Morens on the need for developing broadly protective coronavirus vaccines.

    Jan 26, 2022·14m
  383. 383

    NEJM Interview: Dr. L. Ebony Boulware on the importance of racial and ethnic diversification and increased focus on equity in clinical and translational research.

    Jan 19, 2022·13m
  384. 384

    Crushing the Covid-19 Curve

    Jan 19, 2022·41m
  385. 385

    NEJM Interview: Dr. Debra Weinstein on the pandemic’s effects on graduate medical education and what we can learn from them.

    Jan 12, 2022·13m
  386. 386

    Covid-19 Takeaways at Podcast 100

    Jan 12, 2022·30m
  387. 387

    NEJM Interview: Dr. Joshua Sharfstein on the haphazard organization of U.S. public health at the local, state, and federal levels.

    Jan 5, 2022·9m
  388. 388

    Covid-19 — The Outlook in Europe

    Jan 5, 2022·29m
  389. 389

    NEJM Interview: Dr. Jennifer Lucero on aversive racism as a contributor to structural racism in academic medicine.

    Dec 29, 2021·11m
  390. 390

    Covid-19 Vaccination and the Omicron Variant

    Dec 29, 2021·35m
  391. 391

    NEJM Interview: Dr. Nicole Redvers on Covid-19 vaccination efforts in American Indian and Alaska Native communities.

    Dec 22, 2021·8m
  392. 392

    A Potential New Agent to Treat Covid-19

    Dec 22, 2021·29m
  393. 393

    NEJM Interview: Dr. Jacob Bor on barriers to disseminating information about HIV treatment as a strategy for preventing virus transmission.

    Dec 15, 2021·13m
  394. 394

    How Much Protection Does Prior SARS-CoV-2 Infection Provide?

    Dec 15, 2021·24m
  395. 395

    Waning Immunity against SARS-CoV-2

    Dec 8, 2021·20m
  396. 396

    NEJM Interview: Dr. Janine Knudsen on the experience of safety-net health systems during the Covid-19 pandemic and supporting them moving forward.

    Dec 8, 2021·8m
  397. 397

    NEJM Interview: Dr. Colleen Barry on using public policy to improve population health.

    Dec 1, 2021·12m
  398. 398

    The Omicron Variant of SARS-CoV-2

    Dec 1, 2021·24m
  399. 399

    NEJM Interview: Dr. James Robinson on the aducanumab experience and the structural factors responsible for high drug prices in the United States.

    Nov 24, 2021·11m
  400. 400

    What’s Gone Right in Our Battle against Covid-19

    Nov 24, 2021·29m
  401. 401

    NEJM Interview: Dr. Rena Conti on strategies for regulating drug prices while promoting the development of new pharmaceuticals.

    Nov 17, 2021·9m
  402. 402

    The Legal Basis for Covid-19 Restrictions and Mandates

    Nov 17, 2021·35m
  403. 403

    The Legal Basis for Covid-19 Restrictions and Mandates

    Nov 17, 2021·35m
  404. 404

    Covid-19 in Brazil and New Evidence for Vaccinating Younger Children

    Nov 10, 2021·35m
  405. 405

    NEJM Interview: Dr. Jeffrey Baker on a short-lived 1921 law that supported U.S. women and children.

    Nov 10, 2021·9m
  406. 406

    NEJM Interview: Dr. Elena Fuentes-Afflick on how focusing on the health and needs of subpopulations can advance population health.

    Nov 3, 2021·6m
  407. 407

    Do We Have the Tools to End the Covid-19 Pandemic?

    Nov 3, 2021·23m
  408. 408

    NEJM Interview: Dr. Marshall Chin on gaps and inequities in the health care system’s approach to managing chronic diseases.

    Oct 27, 2021·8m
  409. 409

    A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children

    Oct 27, 2021·22m
  410. 410

    A New Look at Covid-19 Vaccine Boosters

    Oct 20, 2021·21m
  411. 411

    NEJM Interview: Dr. Sasha Mallett on parenting during the Covid-19 pandemic as a person at high risk for infection and related harm.

    Oct 20, 2021·13m
  412. 412

    NEJM Interview: Prof. R. Alta Charo on a law that allows members of the public to file suit to stop abortions in Texas.

    Oct 13, 2021·12m
  413. 413

    Reporting on Covid-19

    Oct 13, 2021·35m
  414. 414

    NEJM Interview: Dr. Miguel Hernán on the use of observational data to inform public health and clinical care decisions.

    Oct 6, 2021·9m
  415. 415

    Are Covid-19 Vaccine Boosters Necessary?

    Oct 6, 2021·25m
  416. 416

    Audio of Perspective Roundtable on Race in Medicine

    Sep 29, 2021·1h
  417. 417

    NEJM Interview: Jessica Leston on challenges facing the system that provides health care to American Indians and Alaska Natives.

    Sep 29, 2021·10m
  418. 418

    Covid-19 and the Media

    Sep 29, 2021·28m
  419. 419

    Vaccine Efficacy and Boosters in Covid-19

    Sep 22, 2021·22m
  420. 420

    NEJM Interview: Prof. Michelle Mello on legal cases related to Covid-19 emergency orders and the future of public health law.

    Sep 22, 2021·11m
  421. 421

    NEJM Interview: Prof. Erin Fuse Brown on lessons from U.S. states that have enacted public option health plans

    Sep 15, 2021·12m
  422. 422

    New Evidence on SARS-CoV-2 Vaccine Boosters

    Sep 15, 2021·18m
  423. 423

    NEJM Interview: Dr. Garth Rapeport on the development and implementation of a SARS-CoV-2 human challenge research program.

    Sep 8, 2021·11m
  424. 424

    Protecting against Severe Disease and Transmission

    Sep 8, 2021·20m
  425. 425

    A New Round of Rising Covid-19 Numbers

    Sep 1, 2021·22m
  426. 426

    NEJM Interview: Dr. Octavio Gómez-Dantés on translating the concept of human rights into health benefits for populations.

    Sep 1, 2021·9m
  427. 427

    NEJM Interview: Dr. Gil Rabinovici on the FDA’s controversial approval of a new treatment for Alzheimer’s disease.

    Aug 25, 2021·17m
  428. 428

    Assessing Vaccine Safety

    Aug 25, 2021·18m
  429. 429

    NEJM Interview: Prof. Nicholas Bagley on the Supreme Court’s decision in California v. Texas

    Aug 18, 2021·13m
  430. 430

    Aspects of Covid-19 Immunity

    Aug 18, 2021·18m
  431. 431

    Monoclonal Antibodies and Booster Shots

    Aug 11, 2021·24m
  432. 432

    NEJM Interview: Dr. Steven Phillips on questions and concerns about ongoing symptoms related to Covid-19 in many patients.

    Aug 11, 2021·10m
  433. 433

    Looking Back and Looking Forward — Part 2

    Aug 4, 2021·25m
  434. 434

    NEJM Interview: Dr. David Hunter on the complementary approaches and achievements of public health and clinical medicine.

    Aug 4, 2021·9m
  435. 435

    NEJM Interview: Dr. Nathaniel Morris on the role of clinicians in programs that provide alternatives to incarceration.

    Jul 28, 2021·16m
  436. 436

    Looking Back and Looking Forward — Part 1

    Jul 28, 2021·30m
  437. 437

    NEJM Interview: Dr. Lucy Marcil on the role of medical–financial partnerships in promoting individual and community health.

    Jul 21, 2021·10m
  438. 438

    The Impact of Covid-19 on Trainees and Junior Faculty

    Jul 21, 2021·43m
  439. 439

    Monoclonal Antibodies and Vaccine Boosts

    Jul 14, 2021·26m
  440. 440

    NEJM Interview: Dr. Suerie Moon on ways of making pandemic vaccines available to all, now and in the future.

    Jul 14, 2021·12m
  441. 441

    NEJM Interview: Dr. Michele Andrasik on promoting Covid-19 vaccine access and uptake by building relationships.

    Jul 7, 2021·18m
  442. 442

    How Well Are Covid-19 Vaccines Working?

    Jul 7, 2021·25m
  443. 443

    Another New Covid-19 Vaccine

    Jun 30, 2021·21m
  444. 444

    NEJM Interview: Dr. J. Michael McGinnis on supporting the evolution of a learning health system.

    Jun 30, 2021·20m
  445. 445

    NEJM Interview: Prof. Sara Rosenbaum on policy and operational challenges related to advancing the Medicaid program.

    Jun 23, 2021·23m
  446. 446

    NEJM Interview: Dr. Reshma Jagsi on the effects of Covid-19 on women in academic medicine and opportunities for promoting equity.

    Jun 16, 2021·10m
  447. 447

    Covid-19 in Children

    Jun 16, 2021·21m
  448. 448

    NEJM Interview: Dr. Anita Allen on progress in protecting health information privacy and the current direction of regulatory momentum.

    Jun 9, 2021·13m
  449. 449

    Treating Complications of Covid Vaccination

    Jun 9, 2021·20m
  450. 450

    NEJM Interview: Dr. Cynthia Stuenkel on medical and policy progress and continued challenges in the field of women’s health.

    Jun 2, 2021·11m
  451. 451

    Vaccinating Children

    Jun 2, 2021·24m
  452. 452

    NEJM Interview: Prof. Scott Burris on the importance of studying the health effects of laws, including laws related to Covid-19.

    May 26, 2021·8m
  453. 453

    Protecting the Immunosuppressed against Covid-19

    May 26, 2021·23m
  454. 454

    Vaccination in Nursing Homes and New Pulmonary/Critical Care Research

    May 19, 2021·29m
  455. 455

    NEJM Interview: Dr. Theresa Williamson on strategies for reducing the burden of the minority tax in academic medicine.

    May 19, 2021·11m
  456. 456

    Vaccination and Variants in the U.S. and South Africa

    May 12, 2021·31m
  457. 457

    NEJM Interview: Dr. Kimberly Sue on federal health policy surrounding harm-reduction approaches to substance use.

    May 12, 2021·8m
  458. 458

    India’s Covid-19 Crisis

    May 5, 2021·36m
  459. 459

    NEJM Interview: Dr. N. Ewen Wang on threats to the health and well-being of immigrant children.

    May 4, 2021·11m
  460. 460

    NEJM Interview: Dr. Joel Negin on the anniversary of sweeping firearm-injury prevention efforts in Australia and lessons for the rest of the world.

    Apr 28, 2021·9m
  461. 461

    Advice for Clinicians on Covid-19 Vaccines and Social Restrictions

    Apr 28, 2021·25m
  462. 462

    Covid-19 Vaccines and Pregnancy — A Conversation with CDC Director Rochelle Walensky

    Apr 21, 2021·30m
  463. 463

    NEJM Interview: Dr. Neil Aggarwal on strategies for enhancing the effectiveness of the Biden administration’s equity agenda.

    Apr 21, 2021·11m
  464. 464

    NEJM Interview: Dr. Andrew Ryan on new legislation to prevent patients from receiving large and unexpected medical bills.

    Apr 14, 2021·12m
  465. 465

    Vaccine Successes and Vaccine Adverse Events

    Apr 14, 2021·24m
  466. 466

    NEJM Interview: Dr. Ingrid Katz on promotion and acceleration of global access to Covid-19 vaccines.

    Apr 7, 2021·12m
  467. 467

    Antibody Responses to Natural Infection and Vaccination

    Apr 7, 2021·19m
  468. 468

    Delivering Covid-19 Vaccines to Minority Communities

    Mar 31, 2021·35m
  469. 469

    NEJM Interview: Dr. Christopher Elias on progress in containing infectious diseases and steps for preventing and countering new threats.

    Mar 31, 2021·9m
  470. 470

    NEJM Interview: Dr. Paul Offit on how more than two centuries of vaccine advances have paved the way for Covid-19 vaccines.

    Mar 24, 2021·7m
  471. 471

    What Earlier Epidemics Teach Us about Covid-19

    Mar 24, 2021·37m
  472. 472

    Efficacy of Current Covid-19 Vaccines against Variant Viruses

    Mar 17, 2021·19m
  473. 473

    NEJM Interview: Dr. Jane Zhu on the growth of private-equity investment in medical practices.

    Mar 17, 2021·8m
  474. 474

    NEJM Interview: Dr. Suchita Rastogi on undertaking medical training as a student with a chronic illness.

    Mar 10, 2021·21m
  475. 475

    The Implications of Changes in the Structural Biology of SARS-CoV-2

    Mar 10, 2021·24m
  476. 476

    A New SARS-CoV-2 Vaccine and a New Look at Treatment

    Mar 3, 2021·23m
  477. 477

    NEJM Interview: Dr. Gary Gibbons on progress in understanding, preventing, and treating atherosclerotic cardiovascular disease.

    Mar 3, 2021·12m
  478. 478

    NEJM Interview: Dr. Thomas Lee on the work that health care organizations will need to take on to ensure effective delivery of Covid-19 vaccines.

    Feb 24, 2021·11m
  479. 479

    The Real-World Effectiveness of Covid-19 Vaccination

    Feb 24, 2021·21m
  480. 480

    NEJM Interview: Dr. Perri Klass on vaccinating children against Covid-19, including lessons from measles vaccination campaigns.

    Feb 17, 2021·12m
  481. 481

    Viral Variants and Covid-19

    Feb 17, 2021·34m
  482. 482

    NEJM Interview: Dr. William Feldman on a new federal price-transparency rule and legal challenges to efforts to increase access to pricing information.

    Feb 10, 2021·12m
  483. 483

    Does Vaccination Mean the End of Masking and Social Distancing?

    Feb 10, 2021·20m
  484. 484

    Covid-19 and the States — A Conversation with Ralph Northam

    Feb 3, 2021·25m
  485. 485

    NEJM Interview: Dr. Julie Gerberding on the past half-century of vaccine development and policy.

    Feb 3, 2021·14m
  486. 486

    NEJM Interview: Dr. Michael Incze on building multidisciplinary care teams for endocarditis and reducing stigma related to substance use.

    Jan 27, 2021·8m
  487. 487

    A Covid-19 Conversation with Anthony Fauci

    Jan 27, 2021·44m
  488. 488

    An International Look at Covid-19

    Jan 20, 2021·43m
  489. 489

    NEJM Interview: Dr. Pardis Sabeti on the importance of testing during an epidemic and why testing approaches in the United States have fallen short.

    Jan 20, 2021·15m
  490. 490

    NEJM Interview: Corey Davis on the recent federal settlement with Purdue Pharma over its actions to increase prescriptions of its opioid medications.

    Jan 13, 2021·9m
  491. 491

    Covid-19 in South Africa and a New SARS-CoV-2 Variant

    Jan 13, 2021·41m
  492. 492

    Planning for the SARS-CoV-2 Vaccine Rollout

    Jan 6, 2021·27m
  493. 493

    NEJM Interview: Dr. Charles Rotimi on advances in human molecular genetics and genomics.

    Jan 6, 2021·12m
  494. 494

    NEJM Interview: Dr. Paula Chatterjee on the role of safety-net hospitals and the challenges associated with defining these facilities.

    Dec 30, 2020·8m
  495. 495

    A Look at Covid-19 Prevention and Care in 2020

    Dec 30, 2020·27m
  496. 496

    NEJM Interview: Dr. Raphael Rush on consent and the gift that patients give when they allow trainees to learn on their bodies.

    Dec 23, 2020·8m
  497. 497

    NEJM Interview: Dr. Daphna Stroumsa on transgender rights, including coverage of gender-affirming health care.

    Dec 16, 2020·12m
  498. 498

    Covid-19 Vaccine Fundamentals

    Dec 16, 2020·20m
  499. 499

    SARS-CoV-2 Vaccination and Vulnerable Populations

    Dec 9, 2020·40m
  500. 500

    NEJM Interview: Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.

    Dec 9, 2020·14m